Skip to main content
OpenTrials
Completed

NCT Number: NCT03199859

Early Diagnosis and Treatment Standardization of Delirium

1. Observe the characteristics of delirium patients, searching for early diagnostic methods or finding risk factors 2. Design a guideline for delirium, diagnosis or treatment

Completed

Looking for future studies?

Notify Me

Key information

About this study

The study is consisted of two parts; First, observational study of gastric cancer patients admitted to hospital, diagnosing the presence of delirium or subsyndromal delirium and collecting patient data, including assessment, self-report surveys, and electronic medical records.

Second, Designing a guideline for treating delirium patients in Korea using the study data and reviewing other studies, guidelines.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Curable malignant gastric cancer

Exclusion criteria

  • Gastrointestinal stromal tumor
  • Uncurable cancer

Treatment and study plan

Primary outcomes

  1. Delirium Rating Scale-98

    Time frame: Till 1 year after surgery

    Delirium rating tool, score of 8 for subsyndromal delirium, 15 for delirium

Secondary outcomes

  1. Functional assessment of cancer therapy - gastric cancer

    Time frame: Till 1 year after surgery

    Quality of life measuring tool for gastric cancer

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Jun 27, 2017
Registry last updated
Sep 23, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.